Tekamlo Side Effects
Generic name: aliskiren / amlodipine
Medically reviewed by Drugs.com. Last updated on May 12, 2023.
Note: This document contains side effect information about aliskiren / amlodipine. Some dosage forms listed on this page may not apply to the brand name Tekamlo.
Applies to aliskiren / amlodipine: oral tablet.
Do not use if you are pregnant. Stop using the medicine and tell your doctor right away if you become pregnant.
If you have diabetes, you should not use aliskiren and amlodipine together with certain heart or blood pressure medicines (such as Accupril, Benicar, Capoten, Cozaar, Diovan, Lotensin, Mavik, Prinivil, Vasotec, and many others).
Get emergency medical help if you have any of these signs of an allergic reaction while taking aliskiren / amlodipine: hives; vomiting, severe stomach pain; dizziness, difficult breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have:
a light-headed feeling, like you might pass out;
chest pain or pressure, pain spreading to your jaw or shoulder;
little or no urinating; or
high potassium--slow heart rate, weak pulse, muscle weakness, tingly feeling.
Common side effects may include:
swelling in your hands, ankles, or feet;
dizziness, tired feeling;
stomach pain, upset stomach; or
flu symptoms (fever, chills, body aches).
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects.
For Healthcare Professionals
Applies to aliskiren / amlodipine: oral tablet.
Rare (less than 0.1%): Hypotension
Common (1% to 10%): palpitations
Rare (less than 0.1%): Myocardial infarction, angina[Ref]
Common (1% to 10%): Rash
Rare (less than 0.1%): Angioedema (involving the face, hands, or whole body)
Postmarketing reports: Severe cutaneous adverse reactions (including Stevens Johnson syndrome and toxic epidermal necrolysis)
Common (1% to 10%): Rash, erythematous rash
Uncommon (0.1% to 1%): Angioedema, erythema multiforme, increased sweating, maculopapular rash, pruritus
Rare (less than 0.1%): Alopecia, dermatitis, skin discoloration, skin dryness, urticaria, lichen planus, telangiectasia[Ref]
Postmarketing reports: Gynecomastia[Ref]
Common (1% to 10%): Diarrhea, abdominal pain, dyspepsia, gastroesophageal reflux (these side effects appear to be dose related)
Postmarketing reports: Nausea, vomiting
Common (1% to 10%): Nausea, dysphagia, abdominal pain
Rare (less than 0.1%): Gastritis, increased appetite, loose stools, taste perversion, dysgeusia[Ref]
Uncommon (0.1% to 1%): Micturition disorder, micturition frequency, nocturia
Rare (less than 0.1%): Dysuria, polyuria[Ref]
Frequency not reported: Angioedema (face, hands, and body) with or without respiratory symptoms
Postmarketing reports: Angioedema
Uncommon (0.1% to 1%): Allergic reaction[Ref]
Postmarketing reports: Jaundice and hepatic enzyme elevations (mostly consistent with cholestasis or hepatitis)-Some cases were severe enough to require hospitalization[Ref]
Uncommon (0.1% to 1%): Elevated uric acid, gout, renal stones
Postmarketing reports: Peripheral edema, hyponatremia
Uncommon (0.1% to 1%): Hyperglycemia, thirst, weight loss, weight gain
Very rare (less than 0.01%): Acute porphyria exacerbation
Frequency not reported: New-onset diabetes[Ref]
Uncommon (0.1% to 1%): Asthenia, rigors
Common (1% to 10%): Myalgia
Uncommon (0.1% to 1%): Arthralgia, arthrosis, muscle cramps
Rare (less than 0.1%): Hypertonia, muscle weakness, twitching, ataxia[Ref]
Frequency not reported: Headache, dizziness, fatigue, episodes of tonic-clonic seizures with loss of consciousness
Common (1% to 10%): Headache, dizziness, somnolence
Uncommon (0.1% to 1%): Hypoesthesia, paresthesia, peripheral neuropathy, postural dizziness, syncope, tinnitus, tremor
Rare (less than 0.1%): Migraine[Ref]
Uncommon (0.1% to 1%): Abnormal vision, conjunctivitis, diplopia, eye pain
Rare (less than 0.1%): Abnormal visual accommodation, xerophthalmia[Ref]
Rare (less than 0.1%): Abnormal dreams, anxiety, depersonalization, depression, insomnia, nervousness, agitation, amnesia, apathy[Ref]
Rare (less than 0.1%): Interstitial nephritis[Ref]
Frequency not reported: Nasopharyngitis, upper respiratory tract infection, cough
Common (1% to 10%): Epistaxis
Uncommon (0.1% to 1%): Dyspnea
Rare (less than 0.1%): Coughing, rhinitis
Postmarketing reports: Pulmonary edema was reported during a study of patients with NYHA Class III or IV heart failure without clinical symptoms or objective evidence of underlying ischemic disease.[Ref]
Rare (less than 0.1%): Parosmia
Frequency not reported: Tinnitus[Ref]
More about Tekamlo (aliskiren / amlodipine)
- Check interactions
- Compare alternatives
- Drug images
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antihypertensive combinations
Related treatment guides
1. Product Information. Tekamlo (aliskiren-amlodipine). Novartis Pharmaceuticals. 2010.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.